Jean Jacques Bienaime, Director at Immunome Inc. (IMNM), bought 7,800 shares at $7.78 ($61K) on 2025-03-25, disclosed to the SEC on 2025-03-26.
Open-market purchase of $61k IMNM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| KROS | BUY | 2026-07-17 | $11K | — | Filing → |
| KROS | BUY | 2026-06-17 | $10K | — | Filing → |
| IMNM | BUY | 2026-06-09 | $204K | — | Filing → |